Hot stock: Best World International's shares surge 14.8% on licence to sell products in China
Add BT as a preferred source
MAINBOARD-LISTED Best World International said on Friday morning its subsidiary, Best World (Zhejiang) Pharmaceutical, has been granted the direct selling licence by the Ministry of Commerce in China.
News of the grant sparked a surge in the shares of the skincare and wellness product manufacturer, making it one of the top 20 gainers on Singapore Exchange.
As at 3.28pm, its counter rose 14.8 per cent or 17 Singapore cents to S$1.32.
Under the licence granted on Thursday, Best World (Zhejiang) Pharmaceutical will be permitted to sell directly its products in China. The specifics as to what categories of products and where in China it can do so will be announced in due course, the group said.
Pursuant to the grant of the licence, Best World (Zhejiang) Pharmaceutical is not permitted to start direct selling of its products until the company sets up the requisite service centres in Hangzhou city within six months from June 7, 2016. These service centres will be subjected to the Chinese authorities' inspection.
Best World (Zhejiang) Pharmaceutical is a wholly owned subsidiary of Best World International's wholly owned subsidiary, Best World Lifestyle.
Share with us your feedback on BT's products and services
TRENDING NOW
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Onitsuka Tiger pivots from Asics stripes to tap luxury market
Singapore to advance AI agenda as Asean chair, focus on cross-border data flows, smaller firms
